Target intelligence / Profile preview

Contact lens deposits

Molecular classification
Other
01

Overview

Contact lens deposits refer to the accumulation of tear film components, including proteins (such as lysozyme, lactoferrin, and albumin), lipids, and mucins, onto the surface and within the matrix of a contact lens during wear (Subbaraman et al., 2006). These biomaterials can undergo denaturation or oxidation, leading to reduced visual acuity, physical discomfort, and inflammatory responses like giant papillary conjunctivitis (Jones et al., 2003). While some proteins like lysozyme maintain antimicrobial activity when adsorbed in their native state, their denaturation can trigger immune reactions and facilitate bacterial adhesion, increasing the risk of microbial keratitis (Willcox, 2013). Management typically involves the use of surfactants and enzymatic cleaners in contact lens care solutions to remove these materials and maintain lens biocompatibility (Stapleton et al., 2008). These cleaning agents, such as poloxamers and proteolytic enzymes, target the deposits to prevent biofouling and ensure the safety of the ocular surface. Although not a single therapeutic target, the study of these deposits is crucial for developing materials with improved resistance to fouling and more effective lens care systems.

Other names
Tear film depositsContact lens biofoulingProtein depositsLipid depositsLens surface contaminants
02

Mechanism of action

Removal of deposits via enzymatic hydrolysis of proteins, solubilization of lipids by surfactants, and oxidative disinfection.

03

Biological functions

Immune responseLubricationBarrier function
04

Disease associations

InfectionInflammationGiant papillary conjunctivitisMicrobial keratitisContact lens-induced acute red eye
05

Safety considerations

Ocular surface toxicityHypersensitivity to cleaning agentsReduced oxygen permeabilityBacterial biofilm formation
06

Interacting drugs

Poloxamer 407

5 more in the full profile.

07

Biomarkers

Denatured lysozyme levelsLipid oxidation productsProtein adsorption rate

Beyond the preview

Go deeper on Contact lens deposits.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Contact lens deposits.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call